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Abstract
Purpose: This research, investigates the viability of using the
Electronic portal imaging device (EPID) coupled with the
treatment planning system (TPS), to calculate the doses de-
livered and verify agreement with the treatment plan. The
results of QA analysis using the EPID, Delta4 and fluence
calculations using the multi-leaf collimator (MLC) dynalog
files on 10 IMRT patients are presented in this study.
Methods: EPID Fluence Images in integrated mode and
Dynalog files for each field were acquired for 10 IMRT
(6MV) patients and processed through an in house MatLab
program to create an opening density matrix (ODM) which
was used as the input fluence for dose calculation with the
TPS (Pinnacle3, Philips). The EPID used in this study was the
aSi1000 Varian on a Novalis TX linac equipped with high
definition MLC. The resulting dose distributions were then
exported to VeriSoft (PTW) where a 3D gamma was calcu-
lated using 3 mm-3% criteria. The Scandidos Delta4 phantom
was also used to measure a 2D dose distribution for all 10
patients and a 2D gamma was calculated for each patient
using the Delta4 software.
Results: The average 3D gamma for all 10 patients using the
EPID images was 98.2% ± 2.6%. The average 3D gamma
using the dynalog files was 94.6% ± 4.9%. The average 2D
gamma from the Delta4 was 98.1% ± 2.5%. The minimum 3D
gamma for the EPID and dynalog reconstructed dose distri-
butions was found on the same patient which had a very
large PTV, requiring the jaws to open to the maximum field
size.
Conclusion: Use of the EPID, combined with a TPS is a via-
ble method for QA of IMRT plans. A larger ODM size can be
implemented to accommodate larger field sizes. An adapta-
tion of this process to Volumetric Arc Therapy (VMAT) is
currently under way.
FIG 1: Fluence map measured by the EPID.
FIG 2: ODM created in Matlab from fluence map.
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TABLE 1: 3D Gammas at 3% 3mm for all 10 patients per QA method.
* = 2D Gamma
FIG. 3: Dose distributions calculated in Pinnacle for the approved plan (left) EPID ODM (middle) and dynalog ODM (right).
